Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurotrauma ; 26(9): 1585-92, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19331516

ABSTRACT

The purpose of this study was to test the effects of exogenous tissue plasminogen activator (tPA) in traumatic brain injury (TBI).We tested two different tPA formulations, free tPA and tPA bound to erythrocytes (RBC/tPA).Vehicle and each of the tPA treatments were injected intravenously into anesthetized rats 15 min after moderate lateral fluid percussion injury. The animals were sacrificed at 2 days for calculating microclot burden (n=13) and IgG staining area (n=13) in the brain sections as indicators of post-traumatic thrombosis and blood-brain barrier (BBB) breakdown, respectively. Another set of injured animals treated in the same way were sacrificed at 7 days to compare cortical lesion volumes (n=28) and CA3 hippocampal cell loss (n=24). All evaluations were done blinded with respect to treatment. No significant differences were found with respect to microclot burden or IgG staining volume. Injection of wild-type tPA caused significantly ( p<0.05) larger cortical injuries and greater cerebral hemorrhage. In contrast, there was significantly less cortical injury ( p<0.01) and hippocampal cell loss ( p<0.01) in the RBC=tPA group than in all other groups. These results reveal that RBC/tPA is more neuroprotective in experimental TBI than is unbound tPA.


Subject(s)
Brain Injuries/drug therapy , Erythrocytes/metabolism , Neuroprotective Agents , Tissue Plasminogen Activator/therapeutic use , Animals , Blood-Brain Barrier/physiology , Brain Injuries/blood , Cell Count , Cerebral Cortex/pathology , Functional Laterality/physiology , Hippocampus/pathology , Humans , Intracranial Hemorrhages/pathology , Intracranial Thrombosis/pathology , Rats , Recombinant Proteins , Tissue Plasminogen Activator/blood
SELECTION OF CITATIONS
SEARCH DETAIL